Plus Therapeutics initiated with a Buy at D. Boral Capital
D. Boral Capital initiated coverage of Plus Therapeutics (PSTV) with a Buy rating and $9 price target Plus is advancing a unique approach in ...
Neural Therapeutics Commences Trading, Provides Update on Growth Initiatives and Engages Investor Relations Consultants
Neural Therapeutics Inc. (CSE: NURL) ("Neural" or the "Company"), an ethnobotanical drug discovery company dedicated to developing therapeutic drugs for mental illnesses related to substance use ...
34 Soothing Self-Care Gifts for Anyone and Everyone Who Needs TLC
When your BFF needs a little TLC, choose one of these thoughtful presents that's sure to promote relaxation, boost ...